Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Hyseq extends cancer gene discovery agreement with Chiron

May 25, 2000

Array BioPharma and Tularik join forces in creating small molecule library

May 25, 2000

Dutch investigators identify potent and selective human A3 receptor antagonist

May 22, 2000

SkyePharma and Pfizer enter second drug delivery agreement

May 22, 2000

Vertex and Novartis create new model for drug discovery

May 18, 2000

Researchers create synthetic vessels to carry biomaterials for gene therapy and other applications

May 18, 2000

Nexell forms cell therapy and gene therapy alliance with Takara Shuzo

May 15, 2000

Acadia and ArQule enter licensing agreement for lead serotonergic compounds

May 15, 2000

Oxford BioMedica acquires development rights to nitroreductase genes

May 11, 2000

Proteomics R&D at Incyte continues to yield new discoveries with diagnostic, therapeutic potential

May 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...